Product NDC: | 0406-8962 |
Proprietary Name: | Dextroamphetamine Sulfate |
Non Proprietary Name: | dextroamphetamine sulfate |
Active Ingredient(s): | 15 mg/1 & nbsp; dextroamphetamine sulfate |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0406-8962 |
Labeler Name: | Mallinckrodt Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076353 |
Marketing Category: | ANDA |
Start Marketing Date: | 20111007 |
Package NDC: | 0406-8962-01 |
Package Description: | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0406-8962-01) |
NDC Code | 0406-8962-01 |
Proprietary Name | Dextroamphetamine Sulfate |
Package Description | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0406-8962-01) |
Product NDC | 0406-8962 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | dextroamphetamine sulfate |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20111007 |
Marketing Category Name | ANDA |
Labeler Name | Mallinckrodt Inc. |
Substance Name | DEXTROAMPHETAMINE SULFATE |
Strength Number | 15 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] |